BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 31116268)

  • 1. Immunoexpression of TS, p53, COX2, EGFR, MSH6 and MLH1 biomarkers and its correlation with degree of differentiation, tumor staging and prognostic factors in colorectal adenocarcinoma: a retrospective longitudinal study.
    Batista WR; Santos G; Vital FMR; Matos D
    Sao Paulo Med J; 2019 May; 137(1):33-38. PubMed ID: 31116268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hierarchical investigating the predictive value of p53, COX2, EGFR, nm23 in the post-operative patients with colorectal carcinoma.
    Du P; Xu B; Zhang D; Shao Y; Zheng X; Li X; Xiong Y; Wu C; Jiang J
    Oncotarget; 2017 Jan; 8(1):954-966. PubMed ID: 27888614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the immunohistochemical expressions of p53, bcl-2 and Ki-67 in colorectal adenocarcinoma and their correlations with the prognostic factors.
    Menezes HL; Jucá MJ; Gomes EG; Nunes BL; Costa HO; Matos D
    Arq Gastroenterol; 2010; 47(2):141-7. PubMed ID: 20721457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular markers identify subtypes of stage III colon cancer associated with patient outcomes.
    Sinicrope FA; Shi Q; Smyrk TC; Thibodeau SN; Dienstmann R; Guinney J; Bot BM; Tejpar S; Delorenzi M; Goldberg RM; Mahoney M; Sargent DJ; Alberts SR
    Gastroenterology; 2015 Jan; 148(1):88-99. PubMed ID: 25305506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the correlation between p53 and bcl-2 expression with staging and prognosis of the colorectal adenocarcinoma.
    Lustosa SA; Logullo A; Artigiani R; Saad SS; Goldenberg A; Matos D
    Acta Cir Bras; 2005; 20(5):353-7. PubMed ID: 16186958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic effect of p53 expression in patients with completely resected colorectal cancer.
    Liu BW; Liu Y; Liu JR; Feng ZX; Liu T
    Tumour Biol; 2014 Oct; 35(10):9893-6. PubMed ID: 24993094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression and prognostic value of ERCC1 and thymidylate synthase in resected gastric adenocarcinoma.
    Squires MH; Fisher SB; Fisher KE; Patel SH; Kooby DA; El-Rayes BF; Staley CA; Farris AB; Maithel SK
    Cancer; 2013 Sep; 119(17):3242-50. PubMed ID: 23719746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ARID1A expression in early stage colorectal adenocarcinoma: an exploration of its prognostic significance.
    Lee LH; Sadot E; Ivelja S; Vakiani E; Hechtman JF; Sevinsky CJ; Klimstra DS; Ginty F; Shia J
    Hum Pathol; 2016 Jul; 53():97-104. PubMed ID: 26980037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of p53 expression and p21 loss has an independent prognostic impact on sporadic colorectal cancer.
    Noske A; Lipka S; Budczies J; Müller K; Loddenkemper C; Buhr HJ; Kruschewski M
    Oncol Rep; 2009 Jul; 22(1):3-9. PubMed ID: 19513497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Switch/sucrose nonfermenting nucleosome complex-deficient colorectal carcinomas have distinct clinicopathologic features.
    Villatoro TM; Ma C; Pai RK
    Hum Pathol; 2020 May; 99():53-61. PubMed ID: 32222462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of protein S100A4 is a predictor of recurrence in colorectal cancer.
    Kwak JM; Lee HJ; Kim SH; Kim HK; Mok YJ; Park YT; Choi JS; Moon HY
    World J Gastroenterol; 2010 Aug; 16(31):3897-904. PubMed ID: 20712050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymidylate synthase and microsatellite instability in colorectal cancer: implications for disease free survival, treatment response and survival with metastases.
    Bendardaf R; Lamlum H; Ristamäki R; Korkeila E; Syrjänen K; Pyrhönen S
    Acta Oncol; 2008; 47(6):1046-53. PubMed ID: 17943475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymidylate synthase and cyclin D1 protein expression in lymph node negative colorectal cancer: role as prognostic factors?
    Formentini A; Henne-Bruns D; Kornmann M
    Hepatogastroenterology; 2012 Sep; 59(118):1859-64. PubMed ID: 22819905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of staging, prognosis and mortality of colorectal cancer by tumor markers: receptor erbB-2 and cadherins.
    Jesus EC; Matos D; Artigiani R; Waitzberg AF; Goldenberg A; Saad SS
    Acta Cir Bras; 2005; 20(6):422-7. PubMed ID: 16302076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of beta-catenin alterations and MSI screening status with expression of key cell cycle regulating proteins and survival from colorectal cancer.
    Wangefjord S; Brändstedt J; Lindquist KE; Nodin B; Jirström K; Eberhard J
    Diagn Pathol; 2013 Jan; 8():10. PubMed ID: 23337059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlations between clinicopathological parameters and molecular signatures of primary tumors for patients with stage T3n0 colorectal adenocarcinomas: a single center retrospective study on 100 cases.
    András C; Tóth L; Molnár C; Tanyi M; Csiki Z; Dezso B; Pósán J; Shemirani AH; Csiki E; Szántó J
    Hepatogastroenterology; 2012 Jun; 59(116):1091-7. PubMed ID: 22414548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathologic features of synchronous colorectal carcinoma: A distinct subset arising from multiple sessile serrated adenomas and associated with high levels of microsatellite instability and favorable prognosis.
    Hu H; Chang DT; Nikiforova MN; Kuan SF; Pai RK
    Am J Surg Pathol; 2013 Nov; 37(11):1660-70. PubMed ID: 23887157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of thymidylate synthase and p53 protein expression on clinical outcome in patients with colorectal cancer.
    Broll R; Busch P; Duchrow M; Oevermann E; Schwandner O; Farke S; Bruch HP; Windhövel U
    Int J Colorectal Dis; 2005 Mar; 20(2):94-102. PubMed ID: 15309465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression of multiple proteins as prognostic factors in colorectal cancer: cathepsin D, p53, COX-2, epidermal growth factor receptor, C-erbB-2, and Ki-67.
    Shin IY; Sung NY; Lee YS; Kwon TS; Si Y; Lee YS; Oh ST; Lee IK
    Gut Liver; 2014 Jan; 8(1):13-23. PubMed ID: 24516696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymidylate synthase expression, p53, bcl-2, Ki-67 and p27 in colorectal cancer: relationships with tumor recurrence and survival.
    Rosati G; Chiacchio R; Reggiardo G; De Sanctis D; Manzione L
    Tumour Biol; 2004; 25(5-6):258-63. PubMed ID: 15627889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.